Pretreatment HIV drug resistance increases regimen switch... | Bernice Hoenderboom

(10:43)

Pretreatment HIV Drug Resistance Spread Within Transmission Clusters in Mexico City

(18:22)

Basics of HIV Drug Resistance Mutations

(1:46:37)

Understanding HIV Drug Resistance

(1:26:39)

HIV Drug Resistance - Raquel Viana

(25:38)

Understanding HIV Infection and HIV Resistance - Jamie Morano, MD

(19:27)

How to Identify the Complex HIV Patient and Approach Treatment - Michael Kozal

(29:40)

The Transition to Dolutegravir-Based ART Regimes: Opportunities and Challenges

(52:22)

Why you should get tested for #HIV

(15:1econd)

The new epidemic of drug resistant HIV-1 | Gillian Hunt, PhD

(26:33)

13 HIV Counselling about preventing transmission of HIV

(5:5)

HIV 101: Fundamentals of HIV Infection and Applications of Antiretroviral Therapy

(1:36:7)

Updates from IAS 2019 Episode 2 – WHO recommendations on the use of Dolutegravir and other ARVs

(52:12)

The art of initiating ART

(35:45)

Webinar: Addressing HIV drug resistance to protect the effectiveness of HIV treatment

(1:45:29)

Dr. Joan Berman: Buprenorphine for HIV-Associated Neurocognitive Disorders

(36:7)

Dr Raja Iskandar - WHO Update on 1st and 2nd line antiretroviral regimen

(24:15)

Nuances of First-line Antiretroviral Therapy in HIV

(6:14)

HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MD

(22:)

Pediatric HIV Treatment Optimization - A Changing Landscape

(1:5:50)